Samaridou E, Heyes J, Lutwyche P. Lipid nanoparticles for nucleic acid supply: present views. Adv Drug Deliv Rev. 2020;154–155:37–63.
Suzuki T, Suzuki Y, Hihara T, Kubara Ok, Kondo Ok, Hyodo Ok, Yamazaki Ok, Ishida T, Ishihara H. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: quicker PEG shedding attenuates anti-PEG IgM manufacturing. Int J Pharm. 2020;588:119792.
Yang C, Lin ZI, Zhang X, Xu Z, Xu G, Wang YM, Tsai TH, Cheng PW, Legislation WC. Ok T Yong, and C Ok Chen. Current advances in Engineering carriers for siRNA supply. Macromol Biosci. 2023: e2300362.
Lamb YN, Inclisiran. First Approval Medication. 2021;81(3):389–95.
Aljabali AAA, Bashatwah RM, Obeid MA, Mishra V, Mishra Y, Serrano-Aroca A, Lundstrom Ok, Tambuwala MM. Present state of, prospects for, and obstacles to mRNA vaccine improvement. Drug Discov At the moment. 2023;28(2):103458.
Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines – a brand new period in vaccinology. Nat Rev Drug Discov. 2018;17(4):261–79.
Pardi N, Tuyishime S, Muramatsu H, Kariko Ok, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by numerous routes. J Management Launch. 2015;217:345–51.
Reichmuth AM, O M, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine supply utilizing lipid nanoparticles. Ther Deliv. 2016;7(5):319–334.
Buschmann MD, Carrasco MJ, Alishetty S, Paige M, Alameh MG, Weissman D. Nanomaterial Supply methods for mRNA vaccines. Vaccines (Basel). 2021;9(1):65.
Wang Q, Jiang Q, Li D, Yang Z, Gao L, Liu F, Li C, Feng Y, He Z, Luo C, Solar J. Elaborately engineering of lipid nanoparticle for concentrating on supply of siRNA and suppressing acute liver harm. Chin Chem Lett. 2024;35(2):108683.
Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, Crommelin DJA. mRNA-lipid nanoparticle COVID-19 vaccines: construction and stability. Int J Pharm. 2021;601:120586.
Carrasco MJ, Alishetty S, Alameh MG, Stated H, Wright L, Paige M, Soliman O, Weissman D, t Cleveland TE, Grishaev A, Buschmann MD. Ionization and structural properties of mRNA lipid nanoparticles affect expression in intramuscular and intravascular administration. Commun Biol. 2021;4(1):956.
Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, Himansu S, Deterling J, Geilich BM, Ketova T, Mihai C, Lynn A, McFadyen I, Moore MJ, Senn JJ, Stanton MG, Almarsson O, Ciaramella G, Brito LA. Optimization of lipid nanoparticles for Intramuscular Administration of mRNA vaccines. Mol Ther Nucleic Acids. 2019;15:1–11.
Li C, Lee A, Grigoryan L, Arunachalam PS, Scott MKD, Trisal M, Wimmers F, Sanyal M, Weidenbacher PA, Feng Y, Adamska JZ, Valore E, Wang Y, Verma R, Reis N, Dunham D, O’Hara R, Park H, Luo W, Gitlin AD, Kim P, Khatri P, Nadeau KC, Pulendran B. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat Immunol. 2022;23(4):543–55.
Billingsley MM, Hamilton AG, Mai D, Patel SK, Swingle KL, Sheppard NC, June CH, Mitchell MJ. Orthogonal Design of experiments for optimization of lipid nanoparticles for mRNA Engineering of CAR T cells. Nano Lett. 2022;22(1):533–42.
Billingsley MM, Singh N, Ravikumar P, Zhang R, June CH, Mitchell MJ. Ionizable lipid nanoparticle-mediated mRNA supply for Human CAR T Cell Engineering. Nano Lett. 2020;20(3):1578–89.
Rurik JG, Tombacz I, Yadegari A, Mendez Fernandez PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Pure E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. CAR T cells produced in vivo to deal with cardiac harm. Science. 2022;375(6576):91–6.
Okuda Ok, Sato Y, Iwakawa Ok, Sasaki Ok, Okabe N, Maeki M, Tokeshi M, Harashima H. On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic gadget. J Management Launch. 2022;348:648–59.
Chatzikleanthous D, D T O’Hagan. Lipid-based nanoparticles for supply of Vaccine adjuvants and antigens: towards Multicomponent vaccines. Mol Pharm. 2021;18(8):2867–88.
Jackman MJ, Li W, Smith A, Workman D, Treacher KE, Corrigan A, Abdulrazzaq F, Sonzini S, Nazir Z, Lawrence MJ, Mahmoudi N, Cant D, Counsell J, Cairns J, Ferguson D, Lenz E, Baquain S, Madla CM, van Pelt S, Moss J, Peter A, Puri S, Ashford M, Mazza M. Influence of the physical-chemical properties of poly(lactic acid)-poly(ethylene glycol) polymeric nanoparticles on biodistribution. J Management Launch. 2024;365:491–506.
Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ concentrating on (SORT) nanoparticles for tissue-specific mRNA supply and CRISPR-Cas gene enhancing. Nat Nanotechnol. 2020;15(4):313–20.
Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA supply by selective organ concentrating on nanoparticles. Proc Natl Acad Sci U S A. 2021;118(52):e2109256118.
Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The consequences of PEGylation on LNP based mostly mRNA supply to the attention. PLoS ONE. 2020;15(10):e0241006.
Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, Dobrovolskaia MA. To PEGylate or to not PEGylate: immunological properties of nanomedicine’s hottest element, polyethylene glycol and its options. Adv Drug Deliv Rev. 2022;180:114079.
Hashiba Ok, Sato Y, Harashima H. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves energetic concentrating on and gene silencing exercise in hepatocytes. J Management Launch. 2017;262:239–46.
Grenier P, Chenard V, Bertrand N. The mechanisms of anti-PEG immune response are totally different within the spleen and the lymph nodes. J Management Launch. 2023;353:611–20.
Suzuki Y, Ishihara H. Construction, exercise and uptake mechanism of siRNA-lipid nanoparticles with an uneven ionizable lipid. Int J Pharm. 2016;510(1):350–8.
Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karagiannis E, Love Ok, Chen D, Zoncu R, Buganim Y, Schroeder A, Langer R, Anderson DG. Effectivity of siRNA supply by lipid nanoparticles is restricted by endocytic recycling. Nat Biotechnol. 2013;31(7):653–8.
Cui L, Hunter MR, Sonzini S, Pereira S, Romanelli SM, Liu Ok, Li W, Liang L, Yang B, Mahmoudi N, Desai AS. Mechanistic research of an automatic lipid nanoparticle reveal essential Pharmaceutical Properties Related to enhanced mRNA purposeful supply in Vitro and in vivo. Small. 2022;18(9):e2105832.
Di J, Du Z, Wu Ok, Jin S, Wang X, Li T, Xu Y. Biodistribution and non-linear gene expression of mRNA LNPs affected by Supply Route and particle dimension. Pharm Res. 2022;39(1):105–14.
Manolova V, Flace A, Bauer M, Schwarz Ok, Saudan P, Bachmann MF. Nanoparticles goal distinct dendritic cell populations in line with their dimension. Eur J Immunol. 2008;38(5):1404–13.
Hassett KJ, Higgins J, Woods A, Levy B, Xia Y, Hsiao CJ, Acosta E, Almarsson O, Moore MJ, Brito LA. Influence of lipid nanoparticle dimension on mRNA vaccine immunogenicity. J Management Launch. 2021;335:237–46.
Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, Wragg KM, Subbarao Ok, Nguyen THO, Rowntree LC, Allen LF, Bond Ok, Williamson DA, Truong NP, Plebanski M, Kedzierska Ok, Mahanty S, Chung AW, Caruso F, Wheatley AK, Juno JA, Kent SJ. Anti-PEG antibodies boosted in people by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano. 2022;16(8):11769–80.
Walsh EE, Frenck RW Jr., Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil Ok, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury Ok, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Tureci O, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU. Sahin, and W C Gruber. Security and Immunogenicity of two RNA-Primarily based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–50.
Estape Senti M, C A de Jongh Ok, Dijkxhoorn JJF, Verhoef J, Szebeni G, Storm CE, Hack RM, Schiffelers MH, Fens, Boross P. Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles by way of complement. J Management Launch. 2022;341:475–86.
Bailey-Hytholt CM, Ghosh P, Dugas J, Zarraga IE, Bandekar A. Formulating and characterizing lipid nanoparticles for gene supply utilizing a microfluidic mixing platform. J Vis Exp. 2021;(168):e62226.
Chen D, Love KT, Chen Y, Eltoukhy AA, Kastrup C, Sahay G, Jeon A, Dong Y, Whitehead KA, Anderson DG. Speedy discovery of potent siRNA-containing lipid nanoparticles enabled by managed microfluidic formulation. J Am Chem Soc. 2012;134(16):6948–51.
Maeki M, Uno S, Niwa A, Okada Y, Tokeshi M. Microfluidic applied sciences and gadgets for lipid nanoparticle-based RNA supply. J Management Launch. 2022;344:80–96.
Huang JL, Jiang G, Music QX, Gu X, Hu M, Wang XL, Music HH, Chen LP, Lin YY, Jiang D, Chen J, Feng JF, Qiu YM, Jiang JY, Jiang XG, Chen HZ, Gao XL. Lipoprotein-biomimetic nanostructure permits environment friendly concentrating on supply of siRNA to ras-activated glioblastoma cells by way of macropinocytosis. Nat Commun. 2017;8:15144.
Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The scale of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene switch. Gene Ther. 2008;15(17):1193–9.
Hunter MR, Cui L, Porebski BT, Pereira S, Sonzini S, Odunze U, Iyer P, Engkvist O, Lloyd RL, Peel S, Sabirsh A, Ross-Thriepland D, Jones AT. Desai. Understanding Intracellular Biology to enhance mRNA supply by lipid nanoparticles. Small Strategies. 2023;7(9):e2201695.
Kim J, Jozic A, Lin Y, Eygeris Y, Bloom E, Tan X, Acosta C, MacDonald KD, Welsher KD, Sahay G. Engineering lipid nanoparticles for enhanced intracellular supply of mRNA by Inhalation. ACS Nano. 2022;16(9):14792–806.
Berger M, Degey M, Leblond Chain J, Maquoi E, Evrard B, Lechanteur A, Piel G. Impact of PEG anchor and serum on lipid nanoparticles: improvement of a nanoparticles monitoring technique. Pharmaceutics. 2023;15(2):597.
Mui BL, Tam YK, Jayaraman M, Ansell SM, Du X, Tam YY, Lin PJ, Chen S, Narayanannair JK, Rajeev KG, Manoharan M, Akinc A, Maier MA, Cullis P, Madden TD, Hope MJ. Affect of polyethylene glycol lipid desorption charges on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol Ther Nucleic Acids. 2013;2(12):e139.
Muller JA, Schaffler N, Kellerer T, Schwake G, Ligon TS, Radler JO. Kinetics of RNA-LNP supply and protein expression. Eur J Pharm Biopharm. 2024;197:114222.
Wilson SC, Baryza JL, Reynolds AJ, Bowman Ok, Keegan ME, Standley SM, Gardner NP, Parmar P, Agir VO, Yadav S, Zunic A, Vargeese C, Lee CC, Rajan S. Actual time measurement of PEG shedding from lipid nanoparticles in serum by way of NMR spectroscopy. Mol Pharm. 2015;12(2):386–92.
Hattori Y, Tamaki Ok, Sakasai S, Ozaki KI, Onishi H. Results of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene–silencing results and siRNA biodistribution in mice. Mol Med Rep. 2020;22(5):4183–96.
Sarode A, Fan Y, Byrnes AE, Hammel M, Hura GL, Fu Y, Kou P, Hu C, Hinz FI, Roberts J, Koenig SG, Nagapudi Ok, Hoogenraad CC, Chen T, Leung D, Yen CW. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing. Nanoscale Adv. 2022;4(9):2107–23.
